From: Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation
 | Obese diabetic | Obese non-diabetic | P value |
---|---|---|---|
Anthropometric and physical characteristics | |||
 Gender (Male/Female) | 118(64/54) | 166 (67/99) | 0.020 |
 Age (years) | 52±9.4 | 40±11.6 | <0.001 |
 BMI (kg/m2) | 31.43 ±4.50 | 29.19 ±5.83 | <0.001 |
 PBF (%) | 36.60 ±8.08 | 34.42 ±6.70 | 0.015 |
 Waist (cm) | 105.19 ±11.36 | 96.80 ±14.51 | <0.001 |
 Hip (cm) | 110.97 ±11.82 | 108.50 ±15.63 | 0.117 |
 WBC10 | 7.34 ±1.93 | 6.57 ±1.79 | <0.001 |
 SBP (mmHg) | 121.83 ±12.13 | 116.87 ±12.18 | 0.001 |
 DBP (mmHg) | 77.28 ±7.47 | 76.15 ±8.11 | 0.210 |
 HR (beats/min) | 82.52 ±13.04 | 78.55 ±11.17 | 0.006 |
 VO2, Max (ml/kg/min) | 15.93 ±4.40 | 19.25 ±4.97 | <0.001 |
Medication | |||
 Anti-diabetic | |||
  Metformin | 72 % | 1% | - |
  Insulin | 36% | - | - |
  Sulfonylurea | 20% | - | - |
  DPP4 inhibitors | 17% | - | - |
  GLP1 analogues | 3% | - | - |
 Anti-hypertensive | 57% | 10% | - |
 Lipid lowering | 69% | 8% | - |
Metabolic markers | |||
 Cholesterol (mmol/l) | 4.98 ±1.29 | 5.07 ±0.92 | 0.489 |
 HDL (mmol/l) | 1.17 ±0.43 | 1.29 ±0.40 | 0.009 |
 LDL (mmol/l) | 3.07 ±1.24 | 3.21 ±0.85 | 0.205 |
 TG (mmol/l) | 1.72 ±1.07 | 1.25 ±1.25 | <0.001 |
 FBG (mmol/l) | 9.04 ±3.64 | 5.30 ±0.72 | <0.001 |
 HbA1c (%) | 7.33 ±1.91 | 5.89 ±0.52 | <0.001 |
 Insulin (ng/ml) | 3.90 ±1.88 | 3.42 ±1.99 | 0.072 |
 C-pep (ng/ml) | 3.98 ±5.26 | 5.12 ±6.12 | 0.135 |
 hsCRP (μg/ml) | 5.67 ±4.31 | 4.63 ±4.36 | 0.109 |
 Fetuin-A (mg/ml) | 1.27 ±0.33 | 1.15 ±0.34 | 0.070 |